Core Scientific colocation revenue rises 58% to $215 million as billing capacity reaches 485 MW
Core Scientific (CORZ) reported Q3 colocation revenue up 58% to $215.4M, total revenue up to $232.9M YoY, and adjusted EBITDA up to $133.6M. Billing capacity reached 485 MW, with capex at $985.1M. Shares dropped 7% to $11.88.
How this was made
The 30-second read
Why it matters
The earnings release provides fresh data on revenue growth versus cash consumption, shaping short‑term price expectations.
Market read
First‑time Q3 earnings release with material numbers; informs traders on immediate price risk and sector trends.
What to watch
Potential upside from the $700M annualized GAAP revenue from colocation and the upcoming CoreWeave buildout.
Background
Core Scientific disclosed its Q3 financials, highlighting rapid growth in colocation capacity and a sizable acquisition, while noting a sharp share decline.
Ticker impact
Q3 colocation revenue rose 58% to $215.4M, total revenue $232.9M, but shares fell 7% on the news.
likely further downside as investors digest elevated capex and shrinking liquidity.
The report shows strong top‑line growth but cash outflows and a large acquisition increase risk, prompting a 7% drop and potential continued sell‑off.
Market effects
AI/HPC data‑center sector faces headwinds as peers also see share declines despite revenue growth.
U.S. tech equities may see modest pressure following the earnings miss on cash metrics.
Limited; impact confined to data‑center and AI infrastructure niche.
Counterpoint
The revenue surge could signal a longer‑term tailwind if capex translates into higher margins later.
Key entities
- CompanyCore Scientific
U.S. data‑center operator reporting Q3 results.
